GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CytoSorbents Corp (NAS:CTSO) » Definitions » Cyclically Adjusted PB Ratio

CytoSorbents (CytoSorbents) Cyclically Adjusted PB Ratio : 1.35 (As of Jun. 07, 2024)


View and export this data going back to 2005. Start your Free Trial

What is CytoSorbents Cyclically Adjusted PB Ratio?

As of today (2024-06-07), CytoSorbents's current share price is $0.888. CytoSorbents's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $0.66. CytoSorbents's Cyclically Adjusted PB Ratio for today is 1.35.

The historical rank and industry rank for CytoSorbents's Cyclically Adjusted PB Ratio or its related term are showing as below:

CTSO' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.22   Med: 16.16   Max: 1185
Current: 1.33

During the past years, CytoSorbents's highest Cyclically Adjusted PB Ratio was 1185.00. The lowest was 1.22. And the median was 16.16.

CTSO's Cyclically Adjusted PB Ratio is ranked better than
64.56% of 474 companies
in the Medical Devices & Instruments industry
Industry Median: 2.09 vs CTSO: 1.33

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

CytoSorbents's adjusted book value per share data for the three months ended in Mar. 2024 was $0.349. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.66 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


CytoSorbents Cyclically Adjusted PB Ratio Historical Data

The historical data trend for CytoSorbents's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CytoSorbents Cyclically Adjusted PB Ratio Chart

CytoSorbents Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 247.42 18.52 4.10 1.78

CytoSorbents Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.60 7.07 3.31 1.78 1.43

Competitive Comparison of CytoSorbents's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, CytoSorbents's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CytoSorbents's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CytoSorbents's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where CytoSorbents's Cyclically Adjusted PB Ratio falls into.



CytoSorbents Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

CytoSorbents's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.888/0.66
=1.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CytoSorbents's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, CytoSorbents's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.349/131.7762*131.7762
=0.349

Current CPI (Mar. 2024) = 131.7762.

CytoSorbents Quarterly Data

Book Value per Share CPI Adj_Book
201406 -0.744 100.560 -0.975
201409 -0.836 100.428 -1.097
201412 0.170 99.070 0.226
201503 0.392 99.621 0.519
201506 0.465 100.684 0.609
201509 0.372 100.392 0.488
201512 0.323 99.792 0.427
201603 0.247 100.470 0.324
201606 0.153 101.688 0.198
201609 0.054 101.861 0.070
201612 0.052 101.863 0.067
201703 -0.061 102.862 -0.078
201706 0.281 103.349 0.358
201709 0.333 104.136 0.421
201712 0.354 104.011 0.448
201803 0.482 105.290 0.603
201806 0.686 106.317 0.850
201809 0.634 106.507 0.784
201812 0.533 105.998 0.663
201903 0.466 107.251 0.573
201906 0.357 108.070 0.435
201909 0.208 108.329 0.253
201912 0.105 108.420 0.128
202003 0.590 108.902 0.714
202006 0.661 108.767 0.801
202009 1.858 109.815 2.230
202012 1.833 109.897 2.198
202103 1.785 111.754 2.105
202106 1.716 114.631 1.973
202109 1.624 115.734 1.849
202112 1.439 117.630 1.612
202203 1.274 121.301 1.384
202206 1.091 125.017 1.150
202209 0.897 125.227 0.944
202212 0.811 125.222 0.853
202303 0.660 127.348 0.683
202306 0.545 128.729 0.558
202309 0.417 129.860 0.423
202312 0.429 129.419 0.437
202403 0.349 131.776 0.349

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


CytoSorbents  (NAS:CTSO) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


CytoSorbents Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of CytoSorbents's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


CytoSorbents (CytoSorbents) Business Description

Traded in Other Exchanges
Address
305 College Road East, Princeton, NJ, USA, 08540
CytoSorbents Corp is involves in the treatment of life-threatening conditions in the intensive care (ICU) and cardiac surgery using blood purification via proprietary polymer adsorption technology. It has a number of products commercialized and in development based on this technology platform.
Executives
Edward Raymond Jones director 70 HOGAN LANE, AMBLER PA 19002
Kathleen P. Bloch officer: Chief Financial Officer 3 PERSHING COURT, NORTH BRUNSWICK NJ 08902
Vincent Capponi officer: Chief Operating Officer MEDASORB TECHNOLOGIES, 7 DEER PARK DRIVE, SUITE K, MONMOUTH JUNCTION NJ 08852
Phillip P. Chan director, officer: President and CEO 1001 BRIGGS ROAD, SUITE 280, MOUNT LAUREL NJ 08054
Efthymios Deliargyris officer: Chief Medical Officer C/O PLX PHARMA,INC.8285 EL RIO STREET, SUITE 210, HOUSTON TX 77054
Jiny Kim director C/O CYTOSORBENTS CORPORATION, 7 DEER PARK DRIVE, SUITE K, MONMOUTH JUNCTION NJ 08852
Alan D. Sobel director 293 EISENHOWER PARKWAY, LIVINGSTON NJ 07039
Michael G. Bator director C/O CYTOSORBENTS CORP., 7 DEER PARK DR., SUITE K, MONMOUTH JUNCTION NJ 08852
Alex D'amico officer: Chief Financial Officer 10 EAST PASSAIC AVENUE, UNIT C-2, NUTLEY NJ 07110
Al Kraus director MEDASORB TECHNOLOGIES, 7 DEER PARK DRIVE, SUITE K, MONMOUTH JUNCTION NJ 08852
Eric R. Mortensen officer: Chief Medical Officer C/O CYTOSORBENTS CORPORATION, 7 DEER PARK DRIVE, SUITE K, MONMOUTH JUNCTION NJ 08852
Njtc Investment Fund, Lp 10 percent owner 1001 BRIGGS ROAD, SUITE 280, MOUNT LAUREL NJ 08054
Robert Shipley 10 percent owner 9 NOBLE ROAD, NOGALES AZ 85621
Ronald Berger officer: See Remarks 7 DEERPARK DRIVE, STE K, MONMOUTH JUNCTION NJ 08852
Thomas Bocchino officer: Chief Financial Officer C/O CYTOSORBENTS CORP., 7 DEER PARK DRIVE, SUITE K, MONMOUTH JUNCTION NJ 08852